Does Blood Type Influence COVID-19 Survival?

Early in the pandemic, researchers scrambled to identify risk factors that might explain why some people fared worse than others. One surprising clue emerged from studies examining the link between blood type and COVID-19 outcomes. Contrary to what some might expect, it wasn’t blood type A or B that showed the highest mortality rate—it was blood type O.

One study revealed a striking pattern: among hospitalized patients, those with blood type O experienced a mortality rate of 46.2%, significantly higher than other groups. This was followed by type AB at 41.7%, type B at 26.3%, and type A at just 13.9%. At first glance, this seems to suggest type O individuals are more vulnerable. But there’s more beneath the surface.

Experts caution against drawing simple conclusions. While the numbers appear alarming, they don’t account for regional blood type distribution, comorbidities, or access to healthcare. In many populations, type O is the most common blood type, which could skew hospitalization and mortality statistics. Moreover, other studies have actually suggested that type O might offer some protection against severe infection, complicating the narrative.

The truth is, blood type is just one piece of a much larger puzzle. Factors like age, underlying health conditions, and vaccination status play far more significant roles in determining outcomes. While intriguing, the link between blood type and COVID-19 mortality remains inconclusive and highly debated among scientists.

So, while the data raises interesting questions, it shouldn’t change how individuals perceive their personal risk. Staying informed, vaccinated, and proactive about health remains the best defense—regardless of blood type.

See also

In-depth articles

Related topics